Suppr超能文献

经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者心肌缺血再灌注损伤的代谢组学特征。

Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.

机构信息

Cardiovascular Lipidomics Laboratory, St. Boniface Hospital, Albrechtsen Research Centre, University of Manitoba, Winnipeg, Canada.

Department of Physiology and Pathophysiology, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.

出版信息

Sci Rep. 2019 Aug 13;9(1):11742. doi: 10.1038/s41598-019-48227-9.

Abstract

The aim of the study was to discover the metabolomic changes in plasma that occur during human Ischemia-Reperfusion (I/R) injury and to evaluate the diagnostic utility of plasma metabolomic biomarkers for determination of myocardial injury. Deciphering the details of plasma metabolome in ST-segment elevation myocardial infarction (STEMI) patients before and after primary percutaneous coronary interventions (PPCI) would allow for better understanding of the mechanisms involved during acute myocardial ischemia and reperfusion in humans. We performed a detailed non-targeted metabolomic analysis of plasma from 27 STEMI patients who had undergone PPCI in the first 48 hrs employing a LC-MS approach. Plasma metabolome at ischemic condition was compared to multiple time points after PPCI which allowed us to focus on changes in the reperfusion phase. Classification of the differential metabolites based on chemical taxonomy identified a major role for lipids and lipid-derived molecules. Biochemical pathway analysis identified valine, leucine and isoleucine biosynthesis, vitamin B6 metabolism and glutathione metabolism as the most significant metabolic pathways representing early response to I/R injury. We also identified phenyl alanine, tyrosine, linoleic acid and glycerophospholipid metabolism as the most significant pathways representing late response to I/R injury. A panel of three metabolites pentadecanoic acid, linoleoyl carnitine and 1-linoleoylglycerophosphocholine was discovered to have diagnostic value in determining the extent of I/R injury based on cardiac biomarkers. Using a non-targeted LC-MS approach, we have successfully generated the most comprehensive data to date on significant changes in the plasma metabolome in STEMI patients who had undergone PPCI in the first 48 hrs showing that lipid metabolites represent the largest cohort of molecules undergoing significant change.

摘要

本研究旨在发现人类缺血再灌注(I/R)损伤过程中血浆代谢组的变化,并评估血浆代谢组生物标志物在确定心肌损伤中的诊断效用。解析接受直接经皮冠状动脉介入治疗(PPCI)前后 ST 段抬高型心肌梗死(STEMI)患者血浆代谢组的详细信息,将有助于更好地理解人类急性心肌缺血和再灌注过程中涉及的机制。我们采用 LC-MS 方法对 27 例接受 PPCI 治疗的 STEMI 患者在缺血 48 小时内的血浆进行了详细的非靶向代谢组学分析。将缺血状态下的血浆代谢组与 PPCI 后多个时间点进行比较,使我们能够专注于再灌注期的变化。基于化学分类法对差异代谢物进行分类,确定了脂质和脂质衍生分子的主要作用。生化途径分析确定缬氨酸、亮氨酸和异亮氨酸生物合成、维生素 B6 代谢和谷胱甘肽代谢是代表 I/R 损伤早期反应的最重要代谢途径。我们还确定苯丙氨酸、酪氨酸、亚油酸和甘油磷脂代谢是代表 I/R 损伤晚期反应的最重要途径。发现基于心脏生物标志物,十五烷酸、亚油酰肉碱和 1-亚油酰甘油磷酸胆碱这三种代谢物组成的标志物具有诊断价值,可以确定 I/R 损伤的程度。我们采用非靶向 LC-MS 方法,成功生成了迄今为止接受 PPCI 治疗的 STEMI 患者在最初 48 小时内血浆代谢组变化的最全面数据,结果表明脂质代谢物是经历显著变化的最大分子群体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验